News & Updates
Filter by Specialty:
Show Multimedia Only

Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD
25 Nov 2025
byStephen Padilla
Treatment with semaglutide helps reduce kidney fat and enhance glomerular haemodynamic in adult patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as shown in the REMODEL trial.
Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD
25 Nov 2025
Pivotal phase III trial shows Tx potential of oral carbapenem for cUTI or acute pyelonephritis
20 Nov 2025
byAudrey Abella
Results from the phase III PIVOT-PO study demonstrate the potential of tebipenem pivoxil hydrobromide (TBP-PI) as an effective oral carbapenem antibiotic for the treatment of complicated urinary tract infections (cUTI).







